Glazer Capital LLC’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Glazer Capital LLC’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-860,385	Closed	-$8.49M	–	720
2022 Q3	$8.49M	Hold	860,385	–	–	0.16%	195
2022 Q2	$8.42M	Buy	860,385 +1,392	+0.2%	+$13.7K	0.21%	163
2022 Q1	$8.4M	Buy	858,993 +729,603	+564%	+$7.12M	0.24%	120
2021 Q4	$1.27M	Sell	129,390 -12,251	-9%	-$120K	0.03%	370
2021 Q3	$1.38M	Sell	141,641 -20,817	-13%	-$201K	0.02%	435
2021 Q2	$1.57M	Buy	+162,458	New	+$1.58M	0.02%	458

Glazer Capital LLC's SHAC Position: Q4 2022 in Review

Glazer Capital LLC sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 860,385 shares — an estimated $8.49M sold.

Glazer Capital LLC first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $8.49M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Glazer Capital LLC reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 860,385 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $8.49M.
Glazer Capital LLC first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Glazer Capital LLC's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $8.49M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.